Cargando…

Inhibition of voltage-dependent K(+) channels by antimuscarinic drug fesoterodine in coronary arterial smooth muscle cells

Fesoterodine, an antimuscarinic drug, is widely used to treat overactive bladder syndrome. However, there is little information about its effects on vascular K(+) channels. In this study, voltage-dependent K(+) (Kv) channel inhibition by fesoterodine was investigated using the patch-clamp technique...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Seojin, Kang, Minji, Heo, Ryeon, Mun, Seo-Yeong, Park, Minju, Han, Eun-Taek, Han, Jin-Hee, Chun, Wanjoo, Park, Hongzoo, Park, Won Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437370/ https://www.ncbi.nlm.nih.gov/pubmed/36039740 http://dx.doi.org/10.4196/kjpp.2022.26.5.397

Ejemplares similares

Inhibitory effects of the atypical antipsychotic, clozapine, on voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells
por: Kang, Minji, et al.
Publicado: (2022)

Encainide, a class Ic anti-arrhythmic agent, blocks voltage-dependent potassium channels in coronary artery smooth muscle cells
por: Li, Hongliang, et al.
Publicado: (2023)

Nortriptyline, a tricyclic antidepressant, inhibits voltage-dependent K(+) channels in coronary arterial smooth muscle cells
por: Shin, Sung Eun, et al.
Publicado: (2017)

Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K(+) channels in coronary arterial smooth muscle cells
por: Kim, Han Sol, et al.
Publicado: (2017)

Role of fesoterodine in the treatment of overactive bladder
por: Mansfield, Kylie J
Publicado: (2009)

Physicochemical properties and drug-release mechanisms of dual-release bilayer tablet containing mirabegron and fesoterodine fumarate
por: Lee, Hong-Goo, et al.
Publicado: (2019)

Fesoterodine for the treatment of urinary incontinence and overactive bladder
por: Ellsworth, Pamela
Publicado: (2009)

Comparison of solifenacin and fesoterodine in treatment of overactive bladder
por: Ercan, Önder, et al.
Publicado: (2015)

Use of Antimuscarinics in the Elderly
por: Patel, Bhavin, et al.
Publicado: (2009)

Overactive bladder, differential diagnosis, and clinical utility of fesoterodine
por: Wyndaele, Jean-Jacques
Publicado: (2012)

Inhibition of voltage-dependent K(+) current in rabbit coronary arterial smooth muscle cells by the class Ic antiarrhythmic drug propafenone
por: An, Jin Ryeol, et al.
Publicado: (2018)

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder
por: Heesakkers, John, et al.
Publicado: (2022)

High satisfaction with direct switching from antimuscarinics to mirabegron in patients receiving stable antimuscarinic treatment
por: Liao, Chun-Hou, et al.
Publicado: (2016)

Reliability and validity of the Korean version of the coronary revascularization outcome questionnaire
por: Kim, Minju, et al.
Publicado: (2017)

Osteoclast-Like Giant Cell Carcinoma of the Distal Ureter
por: Park, Hongzoo
Publicado: (2011)

Eosinophilic cystitis with recurrent urinary retention: case report
por: Park, Hongzoo
Publicado: (2017)

Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder
por: Cardozo, Linda, et al.
Publicado: (2010)

Dexmedetomidine Inhibits Voltage-Gated Sodium Channels via α2-Adrenoceptors in Trigeminal Ganglion Neurons
por: Im, Sang-Taek, et al.
Publicado: (2018)

Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder
por: Kaga, Kanya, et al.
Publicado: (2020)

Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity
por: Sano, Yamato, et al.
Publicado: (2023)

Bladder antimuscarinics and cognitive decline in elderly patients
por: Moga, Daniela Claudia, et al.
Publicado: (2017)

Treatment of pediatric antimuscarinic delirium with oral rivastigmine
por: Yakey, Brandtly, et al.
Publicado: (2023)

Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?
por: Morris, Vikky, et al.
Publicado: (2014)

Formulation and evaluation of pH activated dosage form as minitablets in capsule for delivery of fesoterodine
por: Syed, Shoaeb M., et al.
Publicado: (2021)

Natural 10-year history of simple renal cysts
por: Park, Hongzoo, et al.
Publicado: (2015)

An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
por: Athanasopoulos, Anastasios, et al.
Publicado: (2011)

Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study
por: Wyndaele, J-J, et al.
Publicado: (2009)

NGF and HB-EGF: Potential Biomarkers that Reflect the Effects of Fesoterodine in Patients with Overactive Bladder Syndrome
por: Kim, Soo Rim, et al.
Publicado: (2015)

Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines?
por: Heesakkers, John, et al.
Publicado: (2017)

The role of the voltage-gated potassium channel, Kv2.1 in prostate cancer cell migration
por: Park, Hyun Woo, et al.
Publicado: (2021)

Caffeic acid methyl ester inhibits mast cell activation through the suppresion of MAPKs and NF-κB signaling in RBL-2H3 cells
por: Park, Jin-Young, et al.
Publicado: (2023)

Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels
por: Firth, Amy L., et al.
Publicado: (2011)

Ropivacaine-Induced Contraction Is Attenuated by Both Endothelial Nitric Oxide and Voltage-Dependent Potassium Channels in Isolated Rat Aortae
por: Ok, Seong-Ho, et al.
Publicado: (2013)

In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine
por: Howell, G, et al.
Publicado: (2005)

Computational Exploration of Licorice for Lead Compounds against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation
por: Yasir, Muhammad, et al.
Publicado: (2023)

Vismodegib Identified as a Novel COX-2 Inhibitor via Deep-Learning-Based Drug Repositioning and Molecular Docking Analysis
por: Yasir, Muhammad, et al.
Publicado: (2023)

Computational Exploration of the Effects of Mutations on GABA Aminotransferase in GABA Aminotransferase Deficiency
por: Yasir, Muhammad, et al.
Publicado: (2023)

Long-Term Efficacy of Mirabegron Add-On Therapy to Antimuscarinic Agents in Patients With Spinal Cord Injury
por: Han, Seok-Hee, et al.
Publicado: (2019)

Prevention of HIV-1 TAT Protein-Induced Peripheral Neuropathy and Mitochondrial Disruption by the Antimuscarinic Pirenzepine
por: Han, May Madi, et al.
Publicado: (2021)

Y-27632 Induces Neurite Outgrowth by Activating the NOX1-Mediated AKT and PAK1 Phosphorylation Cascades in PC12 Cells
por: Park, So Yeong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lvnsndla5cmj5dok2277tafphl